Dianthus Therapeutics, Inc. (DNTH)
79.22
+1.22
(+1.56%)
USD |
NASDAQ |
Mar 17, 14:05
Dianthus Therapeutics Total Assets (Quarterly) : 531.40M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Daré Bioscience, Inc. | 30.75M |
| Relmada Therapeutics, Inc. | 14.88M |
| Ocugen, Inc. | 44.29M |
| Cartesian Therapeutics, Inc. | 296.41M |
| Stoke Therapeutics, Inc. | 360.26M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 38.00M |
| Shareholders Equity (Quarterly) | 493.40M |
| Debt to Equity Ratio | 0.0028 |
| Current Ratio | 13.32 |
| Net Debt Paydown Yield | -0.01% |